Diseases, Conditions, Syndromes

New tool assesses patients' kidney disease-related knowledge

Many individuals with chronic kidney disease (CKD), particularly those with early stages of the disease, those belonging to minority groups, and those whose primary language is not English, may not have adequate knowledge ...

Medications

Farxiga approved to reduce risk for CKD progression

(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.

page 4 from 33